Codes / ICD10CM / M84.522

M84.522 Pathological fracture in neoplastic disease, left humerus

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Pathological Fracture in Neoplastic Disease, Left Humerus (ICD-10-CM: M84.522)

Summary

This condition describes a bone fracture occurring due to underlying neoplastic (cancerous) disease, specifically involving the left humerus. The fracture results from weakened bone structure caused by the presence of cancer, rather than direct trauma. It is a complication of malignancy affecting the left humerus's bone integrity, which may involve primary bone tumors or metastatic spread to the left humerus region.

Causes

Pathological fractures in neoplastic disease arise when cancerous growths infiltrate or destroy bone tissue in the left humerus, compromising its structural strength. Primary bone cancers (e.g., osteosarcoma) or metastatic tumors (e.g., from breast, lung, or prostate cancer) can erode left humerus bone, leading to spontaneous or minimal-force fractures. Tumor-induced bone destruction or treatment-related effects (e.g., radiation therapy) may also contribute to the weakened bone.

Risk Factors

  • History of cancer, particularly with known bone metastasis to the left humerus.
  • Advanced-stage malignancies with skeletal involvement.
  • Tumors that preferentially affect bone (e.g., multiple myeloma).
  • Prior radiation therapy to left humerus sites.
  • Systemic therapies that weaken bone (e.g., certain chemotherapies).

Symptoms

  • Sudden onset of pain at the left humerus site.
  • Swelling, bruising, or deformity around the left arm.
  • Limited range of motion or inability to bear weight on the left arm.
  • Possible numbness or tingling if nerve involvement occurs.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., X-rays, MRI, or CT scans), and review of the patient's cancer history. Imaging confirms the fracture and identifies underlying neoplastic involvement. Biopsy or prior cancer documentation may be used to verify the neoplastic cause. Laboratory tests (e.g., calcium levels, tumor markers) may support the diagnosis.

Treatment Options

Treatment focuses on stabilizing the fracture, managing pain, and addressing the underlying cancer. Options include immobilization (e.g., splints or braces), surgical fixation (e.g., plates or rods), radiation therapy to reduce tumor burden, and systemic cancer treatments (e.g., chemotherapy or targeted therapy). Pain management and physical therapy are often part of the plan.

Prognosis and Follow-Up

Prognosis depends on the type and stage of the underlying cancer, as well as the fracture's severity. Follow-up includes monitoring for fracture healing, cancer progression, and potential complications. Regular imaging and clinical assessments help guide ongoing care. Rehabilitation may be necessary to restore function.

Complications

  • Nonunion or delayed healing of the fracture.
  • Infection at the fracture site or surgical site.
  • Nerve or vascular damage from the fracture or treatment.
  • Progression of the underlying cancer.
  • Chronic pain or functional impairment.

Lifestyle & Prevention

  • Maintain bone health through adequate calcium and vitamin D intake.
  • Engage in weight-bearing exercises (if appropriate) to strengthen bones.
  • Avoid high-impact activities that could increase fracture risk.
  • Follow cancer treatment plans to manage tumor-related bone weakening.
  • Use assistive devices (e.g., crutches) to reduce stress on the left arm during healing.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden, severe pain in the left arm, visible deformity, or inability to move the arm. Contact your healthcare provider if pain worsens, swelling increases, or you develop new symptoms (e.g., numbness) after a known cancer diagnosis.

Tips for Medical Coders

When coding M84.522, ensure documentation specifies the left humerus and confirms the fracture is pathological (due to neoplastic disease). Include details about the underlying cancer (primary or metastatic) and any encounter type (e.g., initial, subsequent) if applicable. Verify that the fracture is not attributed to trauma to support the pathological classification.

Book a walkthrough

M84.522 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.